Garda Capital Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-800
Closed -$250K 476
2025
Q2
$250K Sell
800
-15,000
-95% -$5.73M 0.01% 523
2025
Q1
$8.28M Buy
+15,800
New +$8.08M 0.21% 143
2024
Q4
Sell
-15,200
Closed -$8.89M 498
2024
Q3
$8.89M Buy
15,200
+7,500
+97% +$4.24M 0.25% 127
2024
Q2
$3.92M Sell
7,700
-5,300
-41% -$2.6M 0.14% 190
2024
Q1
$6.43M Buy
13,000
+10,000
+333% +$5.08M 0.27% 113
2023
Q4
$1.58M Hold
3,000
0.14% 169
2023
Q3
$1.51M Buy
3,000
+1,000
+50% +$492K 0.07% 273
2023
Q2
$961K Sell
2,000
-2,500
-56% -$1.22M 0.05% 246
2023
Q1
$2.13M Sell
4,500
-11,000
-71% -$5.31M 0.1% 157
2022
Q4
$8.22M Buy
+15,500
New +$8.21M 0.45% 48

Other funds holding UNH

Garda Capital Partners's UNH Position: Q1 2024 in Review

Garda Capital Partners sold out of UnitedHealth (UNH) in Q1 2024, closing a stake of 865 shares — an estimated $440K sold.

Garda Capital Partners first reported a position in UNH in Q4 2022 and held it in 5 quarters. The position peaked at $1.59M in Q4 2022. 3,374 funds tracked by Wall St. Rank hold UNH as of Q1 2024.

  • Garda Capital Partners reported no remaining UnitedHealth position as of Q1 2024 after selling out during the quarter.
  • Garda Capital Partners sold 865 UnitedHealth shares in Q1 2024, an estimated $440K.
  • Garda Capital Partners first reported a position in UnitedHealth in Q4 2022 and held it in 5 quarters.
  • Garda Capital Partners's UnitedHealth position peaked at $1.59M in Q4 2022.
  • 3,374 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2024.

Based on Garda Capital Partners's 13F filing for Q1 2024, filed 14 May 2024.